Hemostasis Valves Market: Global Opportunity Analysis and Industry Forecast, 2019-2026 Market

A hemostasis valve is generally used in neuroendovascular procedures to reduce the risk of thromboembolism. Furthermore, a new hemostasis valve that is designed to reduce blood loss has been introduced. In neuroendovascular procedures, a hemostasis valve is used for the continuous irrigation of guides and microcatheters. A conventional hemostasis valve comprises a rotating seal at the end, which is turned open or closed each time a wire or microcatheter/guidewire is introduced or extracted. Often this results in significant back bleeding. When a rotating seal is adjusted sub-optimally during a wire or microcatheter manipulation, the leakage of pressurized saline from the end of a hemostasis valve results in stagnation of blood within a guiding catheter. This becomes a potential source of emboli during a procedure.

COVID-19 scenario analysis:

The COVID-19 is infecting several individuals causing a steep increase in the equipment that can be used for the management of the same. There are various devices, mainly respiratory support devices such as life-support machine, atomizer, oxygen generator, and monitor are among the majorly used medical devices in crucial clinical treatment. COVID-19 has led to sudden increase in demand for medical supplies, which can be used as personal protective equipment including gloves, masks, and protective eyeglasses. The boost in such devices and the personal protective equipment has been observed for both from healthcare professionals and civil population for precautionary measures. The key players who are manufacturing these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the market include, the rise in the number of interventional procedures, which require the hemostasis valves during the surgical procedure, would boost the industry in the coming years. The surge in the mergers and acquisition carried out by the key market leaders, who are the manufacturers of the Hemostasis valves, would help boost the market in the forecast period. The increase in the product launches designed in order to fulfill the demand posed by the market, done by the market players would also help the market gain maximum shares in the coming years. However, the lack of the skilled professionals may hinder the hemostasis valves market growth during the analysis period.

New product advancements to flourish the market

In May 2019, the key leaders Merit Medical Systems, Inc. announced the launch of its PHD (Push, Hold, and Deliver) polycarbonate hemostasis control valve, which is available in the U.S. Also, the dual-seal PHD device allows operators to adjust the valve with one hand by pressing down on the cap, keeping the other hand free for the insertion and withdrawal of diagnostic/interventional devices. Its two seals, which is a primary compression seal and a secondary poly-isoprene push and release bleed back seal, will help physicians reduce blood loss without restricting device movement. The PhD supports for pressure injections up to 400 psi, allows devices up to 7.3F, and features a clear body that provides unobstructed visibility.

In September 2019, Freudenberg Medical announced several new options for medical device companies. The Composer EPIC Catheter Handle Platform delivers next-generation design options through the lumen, modular distal end, and variability of shaft options for electrophysiology guide, diagnostic and therapeutic catheters. The Composer Toccata Catheter Handle Platform is improved for controlling smaller catheter applications up to 9.5Fr OD and provides widespread design flexibility with a variety of shaft options, a proximal Luer connection, and an adaptable tensioning system.

 Surge in mergers and acquisitions to boost the market

In January 2017, Abbott announced that it had completed the acquisition of St. Jude Medical, Inc., starting the company as a leader in the medical device arena. The transaction offers Abbott with expanded opportunities for future growth and is an important part of the company's ongoing effort to advance a robust, diverse portfolio of devices, diagnostics, nutritionals and branded generic pharmaceuticals. 

In February 2017, Teleflex Incorporated, which is a leading global provider of medical technologies for the critical care and surgery, announced the completion of its previously announced acquisition of Vascular Solutions, Inc. Furthermore, the two companies announced a definitive agreement for Teleflex to acquire the issued and outstanding shares of Vascular Solutions common stock for $56.00 per share, in cash.

Key benefits of the report:

• This study presents the analytical depiction of the global hemostasis valves industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global hemostasis valves market share.
• The current market is quantitatively analyzed to highlight the global hemostasis valves market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global hemostasis valves market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the hemostasis valves market research report:

• Which are the leading market players active in the Hemostasis Valves market?
• What current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in tasking further strategic steps?

 Hemostasis Valves Market: Global Opportunity Analysis and Industry Forecast, 2019–2026 Report Highlights